PDL BioPharma Sees Large Growth in Short Interest (PDLI)
PDL BioPharma (NASDAQ:PDLI) was the recipient of a large growth in short interest in July. As of July 31st, there was short interest totalling 33,322,431 shares, a growth of 5.3% from the July 15th total of 31,658,977 shares, AnalystRatings.NET reports. Based on an average daily trading volume, of 2,282,164 shares, the short-interest ratio is currently 14.6 days. Currently, 23.0% of the shares of the stock are sold short.
Shares of PDL BioPharma (NASDAQ:PDLI) opened at 9.45 on Tuesday. PDL BioPharma has a one year low of $7.38 and a one year high of $10.21. The stock’s 50-day moving average is $9.50 and its 200-day moving average is $8.88. The company has a market cap of $1.518 billion and a price-to-earnings ratio of 5.41.
PDL BioPharma, Inc (NASDAQ:PDLI) is a is a biotech company.
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.